Age-Related Clinical Spectrum of Plasmodium knowlesi Malaria and Predictors of Severity

作者:Grigg Matthew J*; William Timothy; Barber Bridget E; Rajahram Giri S; Menon Jayaram; Schimann Emma; Piera Kim; Wilkes Christopher S; Patel Kaajal; Chandna Arjun; Drakeley Christopher J; Yeo Tsin W; Anstey Nicholas M
来源:Clinical Infectious Diseases, 2018, 67(3): 350-359.
DOI:10.1093/cid/ciy065

摘要

Background. Plasmodium knowlesi is increasingly reported in Southeast Asia, but prospective studies of its clinical spectrum in children and comparison with autochthonous human-only Plasmodium species are lacking.
Methods. Over 3.5 years, we prospectively assessed patients of any age with molecularly-confirmed Plasmodium monoinfection presenting to 3 district hospitals in Sabah, Malaysia.
Results. Of 481 knowlesi, 172 vivax, and 96 falciparum malaria cases enrolled, 44 (9%), 71 (41%), and 31 (32%) children aged <= 12 years. Median parasitemia was lower in knowlesi malaria (2480/mu L [interquartile range, 538-8481/mu L]) than in falciparum (9600/mu L; P < .001) and vivax malaria. In P.knowlesi, World Health Organization-defined anemia was present in 82% (95% confidence interval [CI], 67%-92%) of children vs 36% (95%CI, 31%-41%) of adults. Severe knowlesi malaria occurred in 6.4% (95% CI, 3.9%-8.3%) of adults but not in children; the commenst severity criterion was acute kideny injury. No patient had coma. Age, parasitemia, schizont proportion, abdominal pain, and dyspnea were independently associated with severe knowlesi malaria, with parasitemia >15000/mu L the best predictor (adjusted odds ratio, 16.1; negative predictive value, 98.5%; P < .001). Two knowlesi-related adult deaths occurred (fatality rate: 4.2/1000 adults).
Conclusions. Age distribution and parasitemia differed markedly in knowlesi malaria compared to human-only species, with both uncomplicated and severe disease occurring at low parasitemia. Severe knowlesi malaria occurred only in adults; however, anemia was more common in children despite lower parasitemia. Parasitemia independently predicted knowlesi disease severity: Intravenous artesunate is warranted initially for those with parasitemia >15 000/mu L.

  • 出版日期2018-8-1